Sumitomo Pharma’s ORGOVYX Receives Health Canada Approval for Advanced Prostate Cancer Treatment

Sumitomo Pharma’s ORGOVYX Receives Health Canada Approval for Advanced Prostate Cancer Treatment

MISSISSAUGA, Ontario, Oct. 23, 202— In a significant development in the field of advanced prostate cancer treatment, Sumitomo Pharma Canada,…

Read More »